Difference between revisions of "Tau protein"
m |
|||
| Line 47: | Line 47: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 09:09, 25 July 2007
| Template:Infobox header| Tau protein | |
|---|---|
| Tau protein | |
| Substrate peptide name | Tau protein |
| Synonyms | Microtubule-associated protein tau
Neurofibrillary tangle protein |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P10636 |
| Reactive glutamines | Q6, Q88, Q124, Q244, Q276, Q288, Q351, Q424 |
| Reactive lysines | K24, K163, K174, K180, K190, K225, K234, K240, K383, K385 |
| Substrate sequence | MAEPRQEFEVM, GLGDRKDQGGY,
GAPGKQAAAQP, AGHVTQARMVS, APPGQKGQANA, TRIPAKTPPAPKTPPSS, TREPKKVAVVR, AKSRLQTAPVP, GGGKVQIINKK, DLSNVQSKCGS, FKDRVQSKIGS, FRENAKAKTDHGA, MVDSPQLATLA |
| Structure | 1I8H |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:9832162 |
| Notes | Bold indicates the predominant substrate sites for TG2.
Upon TG2 action the protein becomes less susceptible to μ-calpain mediated proteolysis. |
| Template:Infobox header | | |
